Sulfasalazine, an arthritis treatment drug, has proven to work against pancreatic cancer in the lab., a phase 1 trial is not necessary, because it is already proven itself to be safe. It is going straight into a phase 2 trial, and because it is off patent, and listed on the PBS, it will only cost in the vicinity of $ 50 for treatment. It's a win win, and Associate Professor Phoebe Phillips from the University of NSW, says she has never before been so hopeful and optimistic in her career researching the disease.

Arthritis drug repurposed to beat sneaky pancreatic cancer cells (thenewdaily.com.au)